CCL Industries (CCL-B) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
12 Nov, 2025Executive summary
Q3 2025 sales rose 6.3% year-over-year to $1,965.9 million, with 3.7% organic growth and 2.5% from FX tailwinds.
Net earnings for Q3 2025 were $210.8 million, up from $191.7 million in Q3 2024; basic and adjusted EPS were $1.21, up 11% from $1.09 in Q3 2024.
Free cash flow from operations increased to $333.4 million in Q3 2025 from $233 million in Q3 2024.
$467.9 million was returned to shareholders year-to-date through dividends and share repurchases.
Operating income reached $321.8 million, up 11.4% year-over-year, with a margin of 16.4%.
Financial highlights
Adjusted EBITDA for Q3 was $416.1 million, up from $380.7 million in Q3 2024.
Effective tax rate increased to 25.5% from 24.5% due to higher income in high-tax jurisdictions.
Net finance expense decreased to $18.2 million from $19.3 million.
Dividend payout ratio at 27%.
Basic and adjusted EPS for the nine months was $3.61, up from $3.30 (excluding prior year revaluation gain).
Outlook and guidance
CCL segment orders remain stable; CPG customer volumes are soft, but CCL Design is strong.
Avery expects a seasonally slow quarter, except for Horticulture.
Checkpoint faces ongoing tariff risks, especially in MAS and ALS product lines.
Innovia's German plant will continue to incur start-up costs in Q4; label materials markets remain slow.
Modest currency tailwind expected for Q4 2025 if current exchange rates persist.
Latest events from CCL Industries
- Record 2025 sales, earnings, and cash flow drove higher shareholder returns and stable 2026 outlook.CCL-B
Q4 202526 Feb 2026 - Q2 2024 saw record sales, profit, and EPS, driven by organic growth and a major acquisition gain.CCL-B
Q2 20241 Feb 2026 - Q3 delivered strong sales and earnings growth, led by Checkpoint and Innovia, with robust liquidity.CCL-B
Q3 202414 Jan 2026 - Q1 2025 saw record sales, earnings, and cash flow, with robust shareholder returns.CCL-B
Q1 20258 Jan 2026 - Record 2024 sales and earnings, strong cash flow, and positive but cautious 2025 outlook.CCL-B
Q4 20248 Jan 2026 - Q2 2025 saw record adjusted EPS, strong cash flow, and robust shareholder returns despite tariff headwinds.CCL-B
Q2 202523 Nov 2025